|
Expanding the Reach of Clinical Trials |
0.75 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Reducing Intersectional Stigmas to Improve Outcomes in People Impacted by Cancer |
0.75 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Updates in Metastatic Colorectal Cancer |
0.75 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Treatment for Pleural and Peritoneal Mesothelioma |
0.75 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Updates to the Management of Cervical Cancer |
0.75 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Debate: Is the Addition of Polatuzumab Vedotin the New Standard First-Line Therapy for Diffuse Large B-Cell Lymphoma? |
0.75 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
|
Management of Advanced Gastroenteropancreatic Neuroendocrine Tumors |
0.75 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
What is Optimal First-Line Management of Advanced Classic Hodgkin Lymphoma? |
0.75 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
|
The Impact of Frontline Immune Checkpoint Inhibitors on Therapy for Relapsed/Refractory Hodgkin Lymphoma |
0.75 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Review of Oral Targeted Therapies in Acute Myeloid Leukemia |
0.75 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
|
Managing Earlier Integration of Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia |
0.75 |
12/01/2024 - 12:00am to 12/01/2025 - 12:00am |
|
NCCN Tumor Boards: Skin Cancers Except Melanoma - Radiation Therapy Treatment Options |
1.00 |
06/18/2025 - 12:00am to 10/15/2025 - 12:00am |
|
Archived NCCN Tumor Boards: Treatment Options and Navigating Sequencing of Therapies in Relapsed/Refractory Multiple Myeloma |
1.00 |
05/28/2025 - 12:00am to 05/23/2026 - 11:59pm |
|
Dental Care for Patients with Cancer: What Oncologists Need to Know |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Updates to Systemic Therapy for Differentiated Thyroid Cancer |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
Facebook
Twitter
LinkedIn
Forward